GOEL DAVID E. 4
4 · Adaptive Biotechnologies Corp · Filed May 11, 2020
Insider Transaction Report
Form 4
GOEL DAVID E.
Director10% OwnerOther
Transactions
- Award
Stock Option (Right to Buy)
2020-02-13+8,888→ 8,888 totalExercise: $31.71Exp: 2030-02-13→ Common Stock (8,888 underlying)
Footnotes (2)
- [F1]The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.
- [F2]The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.